Sensei Biotherapeutics, Inc. reported earnings results for the second quarter ended June 30, 2023. For the second quarter, the company reported net loss was USD 9.39 million compared to USD 10.54 million a year ago. Basic loss per share from continuing operations was USD 0.31 compared to USD 0.34 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.51 USD | -3.82% | -15.64% | +118.21% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+118.21% | 37.87M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- SNSE Stock
- News Sensei Biotherapeutics, Inc.
- Sensei Biotherapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2023